Six former executives and managers from Arizona-based drugmaker, Insys Therapeutics, face conspiracy charges over what a federal prosecutor calls a "racketeering crime." In this case, according to the indictment, the former employees of the drug manufacturer are alleged to have rewarded doctors for prescribing their spray version of the opiate fentanyl, even when it wasn't medically appropriate.
[...] Three years ago on CNBC, Michael Babich demonstrated the company's drug, "Subsys," a prescription pain reliever for cancer patients which is delivered through a spray. The medication, which the company first sold in 2012, racked up $329 milllion in sales last year. "The device that I brought with me today allows the patient to simply with no priming spray the drug underneath their tongue," Babich explained.
According to the indictment, the defendants "conspired with one another to use bribes and kickbacks" for doctors who "wrote large numbers of... prescriptions, most often for patients who did not have cancer." The scheme allegedly funneled tens or even hundreds of thousands of dollars to practitioners, including one whom a sales representative boasted in an email was running "a very shady pill mill and only accepts cash."